搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Rhodoferax ferrireducens Molybdenum cofactor guanylyltransferase (mobA) CSB-YP633785RAAJ
CSB-EP633785RAAJ
CSB-BP633785RAAJ
CSB-MP633785RAAJ
CSB-EP633785RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens Ribosome maturation factor RimM (rimM) CSB-YP633786RAAJ
CSB-EP633786RAAJ
CSB-BP633786RAAJ
CSB-MP633786RAAJ
CSB-EP633786RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens Integration host factor subunit alpha (ihfA) CSB-YP633787RAAJ
CSB-EP633787RAAJ
CSB-BP633787RAAJ
CSB-MP633787RAAJ
CSB-EP633787RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens Peptide chain release factor 1 (prfA) CSB-YP633788RAAJ
CSB-EP633788RAAJ
CSB-BP633788RAAJ
CSB-MP633788RAAJ
CSB-EP633788RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens 50S ribosomal protein L21 (rplU) CSB-YP633789RAAJ
CSB-EP633789RAAJ
CSB-BP633789RAAJ
CSB-MP633789RAAJ
CSB-EP633789RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens Transaldolase (tal) CSB-YP633790RAAJ
CSB-EP633790RAAJ
CSB-BP633790RAAJ
CSB-MP633790RAAJ
CSB-EP633790RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable DNA replication complex GINS protein PSF1 (R53.6) CSB-YP633791CXY
CSB-EP633791CXY
CSB-BP633791CXY
CSB-MP633791CXY
CSB-EP633791CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable aspartate aminotransferase, cytoplasmic (T01C8.5) CSB-YP633792CXY
CSB-EP633792CXY
CSB-BP633792CXY
CSB-MP633792CXY
CSB-EP633792CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens Arginine--tRNA ligase (argS), partial CSB-YP633793RAAJ
CSB-EP633793RAAJ
CSB-BP633793RAAJ
CSB-MP633793RAAJ
CSB-EP633793RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens Anhydro-N-acetylmuramic acid kinase (anmK) CSB-YP633794RAAJ
CSB-EP633794RAAJ
CSB-BP633794RAAJ
CSB-MP633794RAAJ
CSB-EP633794RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Putative UDP-glucuronosyltransferase ugt-55 (ugt-55), partial CSB-YP633795CXY1
CSB-EP633795CXY1
CSB-BP633795CXY1
CSB-MP633795CXY1
CSB-EP633795CXY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens Chemotaxis response regulator protein-glutamate methylesterase 1 (cheB1) CSB-YP633796RAAJ
CSB-EP633796RAAJ
CSB-BP633796RAAJ
CSB-MP633796RAAJ
CSB-EP633796RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Putative 1-acyl-sn-glycerol-3-phosphate acyltransferase acl-2 (acl-2), partial CSB-YP633797CXY1
CSB-EP633797CXY1
CSB-BP633797CXY1
CSB-MP633797CXY1
CSB-EP633797CXY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC) CSB-YP633798RAAJ
CSB-EP633798RAAJ
CSB-BP633798RAAJ
CSB-MP633798RAAJ
CSB-EP633798RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rab-3-interacting molecule unc-10 (unc-10), partial CSB-YP633799CXY
CSB-EP633799CXY
CSB-BP633799CXY
CSB-MP633799CXY
CSB-EP633799CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens ATP synthase subunit beta 1 (atpD1) CSB-YP633800RAAJ
CSB-EP633800RAAJ
CSB-BP633800RAAJ
CSB-MP633800RAAJ
CSB-EP633800RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable protein ariadne-2 (T12E12.1) CSB-YP633801CXY
CSB-EP633801CXY
CSB-BP633801CXY
CSB-MP633801CXY
CSB-EP633801CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Uncharacterized protein T18D3.7 (T18D3.7) CSB-YP633802CXY
CSB-EP633802CXY
CSB-BP633802CXY
CSB-MP633802CXY
CSB-EP633802CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyclin-dependent kinase 5 activator 1 (cdka-1) CSB-YP633803CXY
CSB-EP633803CXY
CSB-BP633803CXY
CSB-MP633803CXY
CSB-EP633803CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Myotublarin-related protein 3 (mtm-3), partial CSB-YP633804CXY
CSB-EP633804CXY
CSB-BP633804CXY
CSB-MP633804CXY
CSB-EP633804CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>